Videos

Leonhardt Ventures | Howard Leonhardt, CEO

The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics.

Retia Medical | Marc Zemel, CEO

Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients.

Altoida | Travis Bond, CEO

Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur.

Lucid Diagnostics | Lishan Aklog, Chairman

Lucid is developing solutions to help clinicians diagnose and manage the progression of esophageal disease.

Dymicron | Ted Bird, Chief Strategy Officer

Dymicron is an innovation-driven medical technology company that is advancing a new generation of musculoskeletal devices made from Polycrystalline Diamond (PCD)—one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use in all human interbody applications.

Vicarious Surgical | Adam Sachs, CEO

Transforming surgery through robotics and virtual reality. The Vicarious Surgical robot will offer surgeons a 360 degree view and reach within the patient and surgical field.

TibaRay | Jeff Amacker, CEO

TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging.

Nanochon | Ben Holmes, CEO

Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3D printing to create an implant which can permanently repair debilitating joint injuries.

OYE Therapeutics | Brett Dines, CEO

OYE (Open Your Eyes) Therapeutic's intervention is set to remove over $5.5B in annual avoidable costs from US hospitals and surgery centers by solving the defined problem of delayed operating room turnover due to extended emergence time from anesthesia.

Aqua Medical | Lloyd Mencinger, President & CEO

Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy.

Day Zero Diagnostics | Jong Lee, CEO & Co-Founder

Day Zero Diagnostics uses whole genome sequencing and machine learning to modernize infectious disease diagnosis and treatment.

Sonic Incytes | Barry Allen, CEO

Velacur is a portable, handheld ultrasound that integrates machine learning to enhance image guidance, resulting in a confident assessment of liver health in all body types.

AtriAN Medical | Ken Coffey, CEO

AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF)

Spark Biomedical | Daniel Powell, CEO

Spark Biomedical's FDA-cleared Transcutaneous Auricular Neurostimulation (tAN™) is a non-invasive wearable treatment technology for opioid withdrawal relief.

CoLabs Medical | Clay Nolan, CEO

CoLabs is developing The Ventor, an emergency airway and ventilation system to manage the patients airway during cardiac arrest.

AiM Medical Robotics | Bob Cathcart, President & CEO

AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).

Wearable Artificial Organs | Victor Gura, CEO

Wearable Artificial Organs is developing truly portable solutions for use in patients with End Stage Renal Disease (ESRD).

Atlantic Therapeutics | Susan Trent, CEO

Wearable technology designed to treat the root cause of female incontinence. The Innovo device engages the pelvic floor muscles via 30 minute sessions that have been clinically proven to reduce and eliminate leaks due to stress urinary incontinence.

Pulse Infoframe | Femida Gwadry-Sridhar, Founder & CEO

Pulse Infoframe has developed a robust platform for accelerating evidence generation and collaborative research through quality real-world data (“RWD”) at scale.

ATRO Medical | Jan Hunik, CEO

ATRO Medical is developing Trammpolin, a prosthetic meniscus made of anatomically shaped polymer for the replacement of damaged menisci.

Entvantage Diagnostics | Joe Skraba, President & CEO

Entvantage Dx is an in-vitro diagnostic company dedicated to reducing antibiotics for ENT illnesses.

Yolia Health | Alberto Osio, CEO

True Vision Treatment (TVT) is Yolia Health's two step therapeutic process for the treatment of vision problems like presbyopia and myopia.

Nervonik | Barry Keenan, CEO

Developing a miniaturized neuromodulation device for therapeutic applications.

Surgical Automations | Sanket Chauhan, CEO

Surgical Automations is developing autonomous surgical robots for endoscopic diagnostic and interventional procedures.

SmartBreast | James Hugg, CEO

Molecular breast imaging (MBI) technology to more accurately diagnose early-stage breast cancer in women with dense breast tissue.

Melzi | Reid Rutherford, CEO

Unintended retained foreign object (URFO) is the #1 "never-event" in hospitals. Melzi Sharps Finder helps surgeons inspect the surgical area for metal objects during open, laparoscopic, and robotic surgeries.

Pulsify Medical | Iwan van Vijfeijken, CEO

The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.

Roundtable Keynote: A View from All Sides of the Medtech Innovation Table

A lively discussion to explore lessons learned and opportunities ahead.

Web3, NFTs, and Decentralized Science: The Most Important Topic That You Don't Understand (But Should)

How will Web3, NFTs, and Decentralized Science Impact the future of healthcare?

Medtech M&A and Deal-Making Perspectives

Let's find out directly from major strategics on what deals they are hunting for and hear their outlook on M&A activity in the coming year.